GT
CVS icon

Greenleaf Trust’s CVS Health CVS Stock Holding History

Greenleaf Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
17,412
+679
+4% +$60.6K 0.02% 231
2026
Q1 		$1.2M Buy
16,733
+959
+6% +$73.9K 0.01% 293
2025
Q4 		$1.25M Buy
15,774
+1,603
+11% +$126K 0.01% 272
2025
Q3 		$1.07M Sell
14,171
-830
-6% -$56.9K 0.01% 311
2025
Q2 		$1.03M Sell
15,001
-4,948
-25% -$324K 0.01% 305
2025
Q1 		$1.35M Buy
19,949
+3,000
+18% +$180K 0.01% 264
2024
Q4 		$761K Sell
16,949
-6,452
-28% -$362K 0.01% 403
2024
Q3 		$1.47M Sell
23,401
-2,874
-11% -$168K 0.01% 251
2024
Q2 		$1.55M Sell
26,275
-4,075
-13% -$255K 0.01% 218
2024
Q1 		$2.42M Buy
30,350
+2,084
+7% +$159K 0.02% 156
2023
Q4 		$2.23M Sell
28,266
-6,383
-18% -$454K 0.02% 160
2023
Q3 		$2.42M Buy
34,649
+551
+2% +$39K 0.03% 138
2023
Q2 		$2.36M Sell
34,098
-4,722
-12% -$336K 0.03% 144
2023
Q1 		$2.88M Sell
38,820
-156
-0.4% -$13.1K 0.03% 133
2022
Q4 		$3.63M Sell
38,976
-171
-0.4% -$16.5K 0.05% 107
2022
Q3 		$3.73M Buy
39,147
+3,054
+8% +$302K 0.06% 95
2022
Q2 		$3.34M Buy
36,093
+268
+0.7% +$26.2K 0.05% 96
2022
Q1 		$3.63M Buy
35,825
+3,136
+10% +$329K 0.04% 87
2021
Q4 		$3.37M Buy
32,689
+1,516
+5% +$140K 0.04% 89
2021
Q3 		$2.65M Buy
31,173
+1,010
+3% +$84.6K 0.03% 97
2021
Q2 		$2.52M Sell
30,163
-110
-0.4% -$9.01K 0.03% 108
2021
Q1 		$2.28M Buy
30,273
+4,080
+16% +$297K 0.03% 106
2020
Q4 		$1.79M Buy
26,193
+1,737
+7% +$113K 0.02% 118
2020
Q3 		$1.43M Sell
24,456
-1,957
-7% -$122K 0.02% 125
2020
Q2 		$1.72M Sell
26,413
-211
-0.8% -$13.3K 0.03% 106
2020
Q1 		$1.58M Buy
26,624
+2,256
+9% +$151K 0.03% 99
2019
Q4 		$1.81M Buy
24,368
+1,186
+5% +$83.3K 0.03% 108
2019
Q3 		$1.46M Buy
23,182
+1,631
+8% +$96.6K 0.02% 120
2019
Q2 		$1.17M Buy
21,551
+12,436
+136% +$670K 0.02% 151
2019
Q1 		$492K Sell
9,115
-8,671
-49% -$535K 0.01% 269
2018
Q4 		$1.17M Buy
17,786
+3,569
+25% +$266K 0.02% 138
2018
Q3 		$1.12M Buy
14,217
+2,742
+24% +$196K 0.02% 157
2018
Q2 		$738K Buy
11,475
+4,030
+54% +$266K 0.01% 201
2018
Q1 		$463K Sell
7,445
-1,057
-12% -$75.8K 0.01% 250
2017
Q4 		$616K Buy
8,502
+4,008
+89% +$291K 0.01% 209
2017
Q3 		$365K Sell
4,494
-564
-11% -$44.6K 0.01% 275
2017
Q2 		$407K Sell
5,058
-577
-10% -$45.6K 0.01% 229
2017
Q1 		$442K Buy
5,635
+1,935
+52% +$154K 0.01% 172
2016
Q4 		$292K Buy
3,700
+209
+6% +$16.9K 0.01% 181
2016
Q3 		$311K Buy
3,491
+797
+30% +$75.2K 0.01% 155
2016
Q2 		$258K Sell
2,694
-334
-11% -$33.3K 0.01% 153
2016
Q1 		$314K Sell
3,028
-695
-19% -$67.6K 0.01% 134
2015
Q4 		$364K Buy
3,723
+125
+3% +$12.2K 0.01% 123
2015
Q3 		$347K Sell
3,598
-234
-6% -$24.6K 0.01% 130
2015
Q2 		$402K Buy
3,832
+448
+13% +$45.8K 0.01% 115
2015
Q1 		$349K Sell
3,384
-65
-2% -$6.58K 0.01% 125
2014
Q4 		$332K Hold
3,449
– – 0.01% 125
2014
Q3 		$275K Sell
3,449
-558
-14% -$44K 0.01% 132
2014
Q2 		$302K Sell
4,007
-605
-13% -$45.7K 0.01% 129
2014
Q1 		$345K Buy
4,612
+183
+4% +$12.9K 0.01% 124
2013
Q4 		$317K Buy
4,429
+65
+1% +$4.18K 0.01% 130
2013
Q3 		$248K Buy
4,364
+484
+12% +$28.8K 0.01% 139
2013
Q2 		$222K Buy
+3,880
New +$225K 0.01% 148

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Greenleaf Trust's CVS Position: Q2 2026 in Review

Greenleaf Trust increased its CVS Health (CVS) stake by 4.1% in Q2 2026, buying an estimated $60.6K and bringing the position to 17,412 shares worth $1.8M. The position accounts for 0.02% of the portfolio, ranked #231.

Greenleaf Trust first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.73M in Q3 2022. 505 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Greenleaf Trust held 17,412 shares of CVS Health worth $1.8M as of Q2 2026.
  • Greenleaf Trust bought 679 CVS Health shares in Q2 2026, an estimated $60.6K.
  • CVS Health made up 0.02% of Greenleaf Trust's portfolio in Q2 2026, its #231 holding.
  • Greenleaf Trust first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Greenleaf Trust's CVS Health position peaked at $3.73M in Q3 2022.
  • 505 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.